Literature DB >> 19041572

Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging.

Zoran B Popović1, Deborah H Kwon, Micky Mishra, Adisai Buakhamsri, Neil L Greenberg, Maran Thamilarasan, Scott D Flamm, James D Thomas, Harry M Lever, Milind Y Desai.   

Abstract

The relationship among myocardial fibrosis, segmental strains, and hypertrophic cardiomyopathy (HCM) in patients with preserved left ventricular ejection fraction is not known. We evaluated this relationship in 39 consecutive patients with HCM with transthoracic echocardiography and delayed hyperenhancement magnetic resonance imaging 20 minutes after injection of 0.2 mmol/kg of gadolinium. Speckle tracking echocardiography was used to assess left ventricle strains. Fibrosis was determined semiautomatically with magnetic resonance imaging, using a 12-segment short-axis left ventricular model. Myocardial fibrosis was detected in 23 of 39 patients with HCM. The mean end-systolic longitudinal strain correlated with the number of fibrotic segments (r = 0.47, P =.002) and total myocardial fibrosis (r = 0.46, P =.003). Fibrosis and wall thickness were both multivariate predictors of lower segmental longitudinal strain (P <.003). Longitudinal, circumferential, and radial strains are decreased in patients with HCM even in the absence of fibrosis. Myocardial fibrosis is associated with depressed longitudinal strain in patients with HCM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19041572     DOI: 10.1016/j.echo.2008.09.011

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  57 in total

1.  Subclinical left ventricular systolic impairment in steady state young adult patients with sickle-cell anemia.

Authors:  Nadjib Hammoudi; Dimitri Arangalage; Morad Djebbar; Katia Stankovic Stojanovic; Magali Charbonnier; Richard Isnard; Robert Girot; Pierre-Louis Michel; François Lionnet
Journal:  Int J Cardiovasc Imaging       Date:  2014-06-22       Impact factor: 2.357

2.  Late gadolinium enhancement confined to the right ventricular insertion points in hypertrophic cardiomyopathy: an intermediate stage phenotype?

Authors:  Paco E Bravo; Hong-Chang Luo; Iraklis Pozios; Stefan L Zimmerman; Celia Pamela Corona-Villalobos; Lars Sorensen; Ihab R Kamel; David A Bluemke; Richard L Wahl; M Roselle Abraham; Theodore P Abraham
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-06-14       Impact factor: 6.875

3.  Left ventricular function in patients with hypertrophic cardiomyopathy and its relation to myocardial fibrosis and exercise tolerance.

Authors:  Dimitrios Maragiannis; Paulino A Alvarez; Mohamad G Ghosn; Karen Chin; Jeremy J Hinojosa; John M Buergler; Dipan J Shah; Sherif F Nagueh
Journal:  Int J Cardiovasc Imaging       Date:  2017-07-26       Impact factor: 2.357

4.  Two-dimensional strain analysis of the global and regional myocardial function for the differentiation of pathologic and physiologic left ventricular hypertrophy: a study in athletes and in patients with hypertrophic cardiomyopathy.

Authors:  T Butz; F van Buuren; K P Mellwig; C Langer; G Plehn; A Meissner; H J Trappe; D Horstkotte; L Faber
Journal:  Int J Cardiovasc Imaging       Date:  2010-07-10       Impact factor: 2.357

5.  Three-dimensional speckle tracking echocardiography for the preclinical diagnosis of hypertrophic cardiomyopathy.

Authors:  Mohamed F A Aly; Wessel P Brouwer; Sebastiaan A Kleijn; Albert C van Rossum; Otto Kamp
Journal:  Int J Cardiovasc Imaging       Date:  2014-01-30       Impact factor: 2.357

6.  Speckle tracking echocardiography detects uremic cardiomyopathy early and predicts cardiovascular mortality in ESRD.

Authors:  Rafael Kramann; Johanna Erpenbeck; Rebekka K Schneider; Anna B Röhl; Marc Hein; Vincent M Brandenburg; Merel van Diepen; Friedo Dekker; Nicolaus Marx; Jürgen Floege; Michael Becker; Georg Schlieper
Journal:  J Am Soc Nephrol       Date:  2014-04-03       Impact factor: 10.121

7.  Effects of hypertrophy and fibrosis on regional and global functional heterogeneity in hypertrophic cardiomyopathy.

Authors:  Sung-A Chang; Sang-Chol Lee; Yeon Hyeon Choe; Hye-Jin Hahn; Shin Yi Jang; Sung-Ji Park; Jin-Oh Choi; Seung Woo Park; Jae K Oh
Journal:  Int J Cardiovasc Imaging       Date:  2012-10-25       Impact factor: 2.357

Review 8.  Perioperative assessment of myocardial deformation.

Authors:  Andra E Duncan; Andrej Alfirevic; Daniel I Sessler; Zoran B Popovic; James D Thomas
Journal:  Anesth Analg       Date:  2014-03       Impact factor: 5.108

9.  Characteristic systolic waveform of left ventricular longitudinal strain rate in patients with hypertrophic cardiomyopathy.

Authors:  Kazunori Okada; Sanae Kaga; Taisei Mikami; Nobuo Masauzi; Ayumu Abe; Masahiro Nakabachi; Shinobu Yokoyama; Hisao Nishino; Ayako Ichikawa; Mutsumi Nishida; Daisuke Murai; Taichi Hayashi; Chikara Shimizu; Hiroyuki Iwano; Satoshi Yamada; Hiroyuki Tsutsui
Journal:  Heart Vessels       Date:  2016-10-18       Impact factor: 2.037

10.  Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.

Authors:  Pranoti Hiremath; Patrick R Lawler; Jennifer E Ho; Andrew W Correia; Siddique A Abbasi; Raymond Y Kwong; Michael Jerosch-Herold; Carolyn Y Ho; Susan Cheng
Journal:  Circ Heart Fail       Date:  2016-09       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.